Biopharmaceutical optimization in neglected diseases for paediatric patients by applying the provisional paediatric biopharmaceutical classification system

Product development programs for neglected tropical diseases: A crucial role for expert meetings

(2017) Leonie Hussaarts et al.   PLoS Neglected Tropical Diseases

Pediatric Biopharmaceutical Classification System: Using Age-Appropriate Initial Gastric Volume

(2016) Ramzi Shawahna   AAPS Journal

European Paediatric Formulation Initiative (EuPFI)—Formulating Ideas for Better Medicines for Children

(2016) Smita Salunke et al.   AAPS PHARMSCITECH

Towards the development of a paediatric biopharmaceutics classification system: Results of a survey of experts

(2016) Hannah Batchelor et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Development of flexible and dispersible oral formulations containing praziquantel for potential schistosomiasis treatment of pre-school age children

(2015) Ramona Trastullo et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Assessment of Age-Related Changes in Pediatric Gastrointestinal Solubility

(2015) Anil R. Maharaj et al.   PHARMACEUTICAL RESEARCH

G.L. Amidon, H. Lennernas, V.P. Shah, and J.R. Crison. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of In Vitro Drug Product Dissolution and In Vivo Bioavailability, Pharm Res 12, 413–420, 1995—Backstory of BCS

(2014) Vinod P. Shah et al.   AAPS Journal

Considerations for a Pediatric Biopharmaceutics Classification System (BCS): Application to Five Drugs

(2014) Shivani V. Gandhi et al.   AAPS PHARMSCITECH

Pediatric drug development: formulation considerations

(2014) Areeg Anwer Ali et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Paediatric biopharmaceutics classification system: Current status and future decisions

(2014) Hannah Batchelor   INTERNATIONAL JOURNAL OF PHARMACEUTICS

A Report from the Pediatric Formulations Task Force: Perspectives on the State of Child-Friendly Oral Dosage Forms

(2013) Anne Zajicek et al.   AAPS Journal

Paediatric oral biopharmaceutics: Key considerations and current challenges

(2013) Hannah K. Batchelor et al.   ADVANCED DRUG DELIVERY REVIEWS

The STEP (Safety and Toxicity of Excipients for Paediatrics) database: Part 2 – The pilot version

(2013) Smita Salunke et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Purely in Silico BCS Classification: Science Based Quality Standards for the World’s Drugs

(2013) Arik Dahan et al.   MOLECULAR PHARMACEUTICS

Summary of the National Institute of Child Health and Human Development–Best Pharmaceuticals for Children Act Pediatric Formulation Initiatives Workshop–Pediatric Biopharmaceutics Classification System Working Group

(2012) Susan M. Abdel-Rahman et al.   CLINICAL THERAPEUTICS

The STEP (Safety and Toxicity of Excipients for Paediatrics) database. Part 1—A need assessment study

(2012) Smita Salunke et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Paediatric pharmacology: Remember the excipients

(2011) Valentina Fabiano et al.   PHARMACOLOGICAL RESEARCH

Improved Albendazole Dissolution Rate in Pluronic 188 Solid Dispersions

(2010) Silvina G. Castro et al.   AAPS PHARMSCITECH

Coexistence of passive and carrier-mediated processes in drug transport

(2010) Kiyohiko Sugano et al.   NATURE REVIEWS DRUG DISCOVERY

Caracterização físico-química do fármaco antichagásico benznidazol

(2010) Flávia Pires Maximiano et al.   QUIMICA NOVA

Prediction of Solubility and Permeability Class Membership: Provisional BCS Classification of the World’s Top Oral Drugs

(2009) Arik Dahan et al.   AAPS Journal

Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatric Formulation Initiative: Selected reports from working groups

(2008) George P. Giacoia et al.   CLINICAL THERAPEUTICS